Vivos Inc Files a New Patent on Alternate Particles for Precision Radionuclide Therapy
11 janv. 2023 09h30 HE
|
Vivos Inc.
Richland WA, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc announced today that the company filed a utility patent application on a range of particles for precision...
Vivos Inc Files a New Patent on the Hydrogel Component of IsoPet®/RadioGel™
14 sept. 2022 09h30 HE
|
Vivos Inc.
Richland WA, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc announced today that they filed a patent application on their hydrogel component of IsoPet/RadioGel in the USA...